Clinical trials: Laparoscopic Sleeve Gastrectomy
Morbid Obesity, Laparoscopic Sleeve Gastrectomy
Pan Immune Inflammation Value for Perioperative Complications of Laparoscopic Sleeve Gastrectomy
Morbid obesity emerges as a problem that causes serious complications and increased mortality rates. The most effective treatment for morbid obesity today is surgical treatment.
- Conditions
- Morbid Obesity, Laparoscopic Sleeve Gastrectomy, Post Operative Complicaiton
- Trial name
- NCT06284356
- Testing
- Laparoscopic Sleeve Gastrectomy
- Where
- Turkey (Türkiye)
- Volunteers
- 159 people, healthy volunteers welcome
- Sponsor
- Kahramanmaras Sutcu Imam University
Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Bariatric surgery remains the most effective therapy for obesity. Postoperative nausea and vomiting (PONV) are commonly reported following bariatric surgery.
- Trial name
- NCT03435003
- Testing
- Aprepitant 80 mg Oral Capsule, scopolamine transdermal, Total intravenous anesthesia
- Where
- United States
- Volunteers
- 83 people, healthy volunteers welcome
- Sponsor
- Stony Brook University
Dexmedetomidine, Fentanyl
Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy
This study aims to compare the efficacy of dexmedetomidine versus fentanyl during general anesthesia for patients with morbid obesity undergoing laparoscopic sleeve gastrectomy.
- Conditions
- Dexmedetomidine, Fentanyl, Time to Extubation, Morbid Obesity
- Trial name
- NCT06052111
- Testing
- Group F (fentanyl group), Group D (dexmedetomidine group)
- Where
- Egypt
- Volunteers
- 64 people
- Sponsor
- Helwan University
Laparoscopic Sleeve Gastrectomy, Postoperative Nausea and Vomiting
Randomized, Controlled, Single-blind Exploratory Study of the Efficacy and Safety of Wrist and Ankle Acupuncture Intervention on Nausea, Vomiting and Pain After Sleeve Gastric Surgery in Women
PONV is the most common clinical presentation after surgical procedures beyond pain. A retrospective study of our center found that the postoperative incidence of LSG was 77.4%.
- Trial name
- NCT05873270
- Testing
- Wrist and ankle acupuncture
- Where
- China
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- LILIAN GAO
Laparoscopic Sleeve Gastrectomy, Subcostal Transversus Abdominis Plane Block
Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
The study team will be assessing if the unilateral subcostal transversus abdominis plane (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy surgeries.
- Trial name
- NCT03856788
- Testing
- Saline, Bupivacaine
- Where
- United States
- Volunteers
- 43 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Optic Nerve Sheath Diameter, Laparoscopic Sleeve Gastrectomy
Non-invasive Assessment of Intracranial Pressure Using Ocular Sonography in Patients Undergoing Laparoscopic Sleeve Gastrectomy
Laparoscopic gastric sleeve gastrectomy is becoming an increasingly frequent procedure for patients with severe obesity and its related diseases, such as type 2 diabetes, hypertension, dyslipidemia, and sleep apnea.
- Trial name
- NCT05485363
- Testing
- ultrasonographic measurement of the optic nerve sheath diameter
- Volunteers
- 20 people
- Sponsor
- Tanta University
GERD, Bariatric Surgery
Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy
GERD is a prevalent condition worldwide, estimated to be around 20-30 % in North America. Obesity is rapidly increasing with an estimated prevalence of 66% in the adult population in the United States.
- Conditions
- GERD, Bariatric Surgery, Laparoscopic Sleeve Gastrectomy
- Trial name
- CLEAR (NCT04771247)
- Testing
- Cardia Band Ligation
- Sponsor
- Johns Hopkins University
Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy
Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
The investigators of the study want to investigate the complex interactions between glucose metabolism, food intake/weight loss, and different appetite regulating hormones after ESG in comparison with conventional laparoscopic…
- Conditions
- Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, Gut Hormones, Glucose Metabolism Disorders
- Trial name
- NCT04452786
- Testing
- Endoscopic sleeve gastroplasty, Laparoscopic sleeve gastrectomy
- Where
- Denmark
- Sponsor
- Hvidovre University Hospital
Postoperative Pain After Laparoscopic Sleeve Gastrectomy
Intraperitoneal Versus Intravenous Dexmedetomidine for Post-operative Analgesia Following Laparoscopic Sleeve Gastrectomy Surgery
One of most common bariatric surgery is laparoscopic sleeve gastrectomy. Pain after laparoscopic surgery may be due to stretching of the intra-abdominal cavity, peritoneal inflammation, and diaphragmatic irritation caused by…
- Trial name
- NCT04370392
- Testing
- intraperitoneal local anaesthetic instillation
- Where
- Egypt
- Volunteers
- 105 people
- Sponsor
- Tanta University
Laparoscopic Sleeve Gastrectomy, Enhanced Recovery After Surgery
Impact of ERAS in LSG
Patients with BMI >35 and chronic diseases or BMI >40 will be scheduled to receive Laparoscopic Sleeve Gastrectomy (LSG). Two groups are planned according to receive Enhance recovery after surgery (ERAS) protocol or not.
- Conditions
- Laparoscopic Sleeve Gastrectomy, Enhanced Recovery After Surgery, Pain, Postoperative, Nausea, Postoperative
- Trial name
- ERAS-LSG (NCT04442568)
- Testing
- ERAS
- Volunteers
- 100 people
- Sponsor
- Umraniye Education and Research Hospital
Laparoscopic Sleeve Gastrectomy, Cardiovascular Risk Factor
Impact of Sleeve Gastrectomy on Monocyte-to-High-Density Lipoprotein Cholesterol Ratio
The present study hypothesized that significant weight loss is associated with a reduction in the inflammatory markers, leading to diminished cardiovascular risks in patients undergoing laparoscopic sleeve gastrectomy (LGS).
- Conditions
- Laparoscopic Sleeve Gastrectomy, Cardiovascular Risk Factor, Obesity
- Trial name
- NCT04439851
- Volunteers
- 125 people
- Sponsor
- Umraniye Education and Research Hospital
Laparoscopic Sleeve Gastrectomy
Laparoscopic Sleeve Gastrectomy: a Cohort Study
This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method.
- Trial name
- NCT03629808
- Testing
- 4-6cm from starting point of gastrectomy to pylorus, 2-4cm from starting point of gastrectomy to pylorus
- Where
- China
- Volunteers
- 138 people
- Sponsor
- Beijing Friendship Hospital
Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy
ESG vs LSG: Short-term Nutritional Outcomes
To assess endoscopic sleeve gastroplasty in comparison to laparoscopic sleeve gastrectomy before and 3 months after the procedure in terms of multiple nutrition-related factors, quality of life, weight and other related…
- Conditions
- Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, Obesity
- Trial name
- NCT04264364
- Testing
- Laparoscopic sleeve gastrectomy, Endoscopic sleeve gastroplasty
- Where
- Saudi Arabia
- Volunteers
- 57 people
- Sponsor
- King Saud University
Polycystic Ovary Syndrome, Severe Obesity
Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
This is a experimental study, which subjects are obese PCOS patients requiring LSG surgery. Aim to investigate the effects of LSG surgery in PCOS patients whether increases the live birth rate of the offspring.
- Conditions
- Polycystic Ovary Syndrome, Severe Obesity, Laparoscopic Sleeve Gastrectomy
- Trial name
- NCT04151459
- Testing
- Metformin
- Where
- China
- Volunteers
- 18 people
- Sponsor
- RenJi Hospital
Bariatric Surgery Candidate, Laparoscopic Sleeve Gastrectomy
Outcomes of Laparoscopic Sleeve Gastrectomy
The aim of this study is to assess 5 year long-term outcomes of laparoscopic sleeve gastrectomy emphasizing weight loss and modification of comorbidities such as type 2 diabetes mellitus, hypertension and gastroesophageal reflux…
- Conditions
- Bariatric Surgery Candidate, Laparoscopic Sleeve Gastrectomy, Obesity, Morbid
- Trial name
- NCT03983122
- Testing
- Laparoscopic sleeve gastrectomy
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
GERD, Gastroesophageal Reflux Disease
RELIEF Europe Study
The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD).
- Conditions
- GERD, Gastroesophageal Reflux Disease, Obesity, LSG
- Trial name
- NCT02762487
- Testing
- The LINX® Reflux Management System
- Where
- 4 sites in Germany, Italy
- Volunteers
- 7 people
- Sponsor
- Torax Medical Incorporated
Laparoscopic Sleeve Gastrectomy
Reinforcement Method in Laparoscopic Sleeve Gastrectomy
Laparoscopic sleeve gastrectomy is a technically simple popular bariatric operation with acceptable results. Leaks can occur in long staple lines; therefore, variable reinforcement methods are used.
- Trial name
- NCT03051919
- Testing
- observation
- Volunteers
- 118 people, healthy volunteers welcome
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
Minimally Invasive Surgical Procedure, Laparoscopic Gastric Banding
Evaluation of Safety and Efficacy of the EndoLift Liver Retractor
The primary goal of the study is to evaluate the safety of the EndoLift Liver Retractor as an internal laparoscopic liver retraction device.
- Conditions
- Minimally Invasive Surgical Procedure, Laparoscopic Gastric Banding, Laparoscopic Roux-en-Y Gastric Bypass, Laparoscopic Sleeve Gastrectomy
- Trial name
- NCT02008409
- Testing
- EndoLift Liver Retractor
- Where
- United States
- Sponsor
- Duke University